Skip to content

Author

Kai-Kai Lu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Hepatic HSD17B6 promotes lipid accumulation and M1 macrophage polarization via the 9-cis-retinoic acid and RXRα axis.

BACKGROUND Metabolic dysfunction-associated steatohepatitis (MASH) is increasingly prevalent and lacks effective therapies. Hydroxysteroid 17-beta dehydrogenase 6 (HSD17B6), a liver-enriched enzyme involved in retinoid and steroid metabolism, has not been functionally characterized in MASH pathogenesis. METHODS Trans...

Xiao-Na Cheng, Kai-Kai Lu, Zi-Zhen Guo et al. · 0 citations
Sep 2026

PDCD4-driven steatosis via the HNF4A/GK axis is attenuated by the natural compound isosinensetin.

BACKGROUND Programmed cell death factor 4 (PDCD4) has been implicated in various metabolic disorders. However, its role and underlying mechanisms in metabolic dysfunction-associated steatotic liver disease (MASLD) have not been fully elucidated. PURPOSE This study aimed to define the role of PDCD4 in hepatic steatosi...

Xiao-Na Cheng, Kai-Kai Lu, Lu-Yun Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.